Filing Details
- Accession Number:
- 0001567619-19-004921
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-19 18:05:57
- Reporting Period:
- 2019-02-14
- Accepted Time:
- 2019-02-19 18:05:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740689 | Michael Lane | C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092 | Corporate Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-14 | 242 | $0.00 | 3,623 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-14 | 188 | $0.00 | 3,811 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-14 | 221 | $0.00 | 4,032 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-14 | 212 | $0.00 | 4,244 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-14 | 197 | $0.00 | 4,441 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-14 | 324 | $206.94 | 4,117 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-02-15 | 971 | $208.00 | 3,146 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Acquisiton | 2019-02-14 | 8,366 | $0.00 | 8,366 | $206.94 |
| Common Stock | Incentive Stock Option (right-to-buy) | Acquisiton | 2019-02-14 | 483 | $0.00 | 483 | $206.94 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2019-02-14 | 906 | $0.00 | 906 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2019-02-14 | 242 | $0.00 | 242 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2019-02-14 | 188 | $0.00 | 188 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2019-02-14 | 221 | $0.00 | 221 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2019-02-14 | 212 | $0.00 | 212 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2019-02-14 | 197 | $0.00 | 197 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,366 | 2029-02-13 | No | 4 | M | Direct | |
| 483 | 2029-02-13 | No | 4 | M | Direct | |
| 4,016 | No | 4 | M | Direct | ||
| 3,774 | No | 4 | M | Direct | ||
| 3,586 | No | 4 | M | Direct | ||
| 3,365 | No | 4 | M | Direct | ||
| 3,153 | No | 4 | M | Direct | ||
| 2,956 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 592 | Indirect | by spouse |
Footnotes
- Includes a total of 48 shares purchased under the Issuer's Employee Stock Purchase Plan on September 28, 2018 and December 31, 2018.
- Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniaryinterest therein.
- Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020.
- Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017.
- Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
- 9. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
- Not applicable.
Billionaire Hedge Funds
